IDH2 and malignant giant cell tumor: Results showed that mutations of H3F3A were detected in all giant cell tumor of bone and malignant giant cell tumor of bone, and mutations of IDH1/2 (including 10 IDH1 and 5 IDH2) were detected in chondrogenic tumors.